Back
GeneDx Holdings 10K Form
Buy
67
WGS
GeneDx Holdings
Last Price:
$98.49
Seasonality Move:
15.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WGS News And Ratings
See the #1 stock for the next 7 days that we like better than WGS
WGS Financial Statistics
Sales & Book Value
| Annual Sales: | $305.5M |
|---|---|
| Cash Flow: | $-6.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.75 |
| Price / Book: | 11.27 |
Profitability
| EPS (TTM): | -1.96000 |
|---|---|
| Net Income (TTM): | $-52.3M |
| Gross Margin: | $194.4M |
| Return on Equity: | -24.23% |
| Return on Assets: | -12.88% |
GeneDx Holdings Earnings Forecast
Key GeneDx Holdings Financial Ratios
-
The Gross Profit Margin over the past 6 years for WGS is 63.64%.
-
The Selling, General & Administrative Expenses for WGS have been equal to 55.16% of Gross Profit Margin.
-
The Research & Development expenses have been 14.97% of Revenue.
-
The Net Earning history of WGS is -17.12% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
GeneDx Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | WGS |
| Website: | genedx.com |
Debt
| Debt-to-Equity Ratio: | 0.21 |
|---|---|
| Current Ratio: | 3.61 |
| Quick Ratio: | 3.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 52.24 |
WGS Technical Analysis vs Fundamental Analysis
Buy
67
GeneDx Holdings (WGS)
is a Buy
Is GeneDx Holdings a Buy or a Sell?
-
GeneDx Holdings stock is rated a BuyThe current GeneDx Holdings [WGS] share price is $98.47. The Score for WGS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.